November 14, 2024
Tag: Matthew Milowsky
November 14, 2024
Inside Precision Oncology: Bladder Cancer Biomarkers Promise Improved Survival

November 13, 2024
Treatment advances, predictive biomarkers stand to improve bladder cancer care
In an editorial, Matthew Milowsky, MD, FASCO, wrote that the promise of incorporating new treatments and predictive biomarkers to select the right patient for the right treatment every time offers a bright future for bladder cancer patients.
May 8, 2023
Oncology Nursing News: Nivolumab Following Radical Surgery Extends Disease-Free Survival Rates in Bladder Cancer
May 1, 2023
OncLive: Nivolumab Maintains DFS Benefit in MIUC and MIBC After Radical Surgery

December 13, 2022
Bladder cancer: what patients need to know
Each year, nearly 75,000 people are diagnosed with bladder cancer. While more common in men over age 55, bladder cancer can—and does—affect women and men of all ages. Hear from our bladder cancer specialists to learn what newly diagnosed patients and their loved ones should know about bladder cancer.
November 30, 2022
Precision Oncology News: Bladder Cancer Genomic Landscape Study Aims to Engender New Biomarker-Guided Therapies

November 14, 2022
Genetic analysis of the most common type of bladder cancer in patients with metastatic disease yields guidance on treatment options
A genomic study of more than 200 people with the most common type of bladder cancer that has spread could help guide how the cancer would respond to immunotherapy.

June 1, 2022
UNC Lineberger faculty present research at the American Society of Clinical Oncology annual meeting
UNC Lineberger members will be presenting research findings, providing commentary and leading education sessions at the American Society of Clinical Oncology’s 58th annual meeting.
November 24, 2021